FGF21 and Hepatic steatosis: A study showed that FGF21 reduced α-SMA production by inhibiting succinate -GPR91 signaling in HSCs and improved hepatic steatosis and fibrosis in an MCD diet-induced mouse model (Le CT et al., 2018).